1 Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
5. Global Post-Operative Pain Management Market, By Pain Type
5.1 Acute Pain
5.2 Moderate Pain
5.3 Severe Pain
6. Global Post-Operative Pain Management Market, By Product
6.1 Non-Steroidal Anti-Inflammatory Drugs (Nsaids)
6.2 Antiepileptic Drugs
6.3 Cox-2 Inhibitors
6.4 Opioids
6.5 Other Analgesics
7. Global Post-Operative Pain Management Market, By Application
7.1 Cancer Pain
7.2 Arthritic Pain
7.3 Neuropathic Pain
7.4 Musculoskeletal Pain
7.5 Migraine
7.6 Other
8. Global Post-Operative Pain Management Market, By Target Area
8.1 Back
8.2 Legs
8.3 Hand and Arms
8.4 Other
9. Global Post-Operative Pain Management Market, By Region
9.1 Introduction
9.2 America
9.2.1 North America
9.2.1.1 US
9.2.1.1 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.3 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic Of Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest Of Middle East & Africa
10. Competitive Landscape
10.1 Major Strategies Adopted By Market Players
10.1.1 Strategic Partnership
10.1.2 Merger & Acquisition
11 Company Profile
11.1 Teva Pharmaceutical Industries Ltd.
11.1.1 Overview
11.1.2 Product Overview
11.1.3 Financials
11.1.4 Key Developments
11.2 Eli Lilly
11.2.1 Overview
11.2.2 Product Overview
11.2.3 Financials
11.2.4 Key Developments
11.3 Pfizer
11.3.1 Overview
11.3.2 Product Overview
11.3.3 Financials
11.3.4 Strategy
11.3.5 Key Development
11.4 Johnson & Johnson
11.4.1 Overview
11.4.2 Product Overview
11.4.3 Financials
11.4.4 Key Developments
11.5 Purdue Pharma
11.5.1 Overview
11.5.2 Product Overview
11.5.3 Financials
11.5.4 Key Developments
11.6 Others
11 Conclusion
12.1 Key Findings
12.1.1 From Ceo’s Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Post-Operative Pain Management Industry
13 Appendix
